9-(2-aminopyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-[2-(hydroxymethyl)pyrimidin-5-yl]-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-(2-methoxypyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(2-methylpyrimidin-5-yl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(6-morpholin-4-yl-3-pyridinyl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-1-piperidin-4-yl-9-(6-pyrazol-1-yl-3-pyridinyl)-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one
C158H176N52O10 — CID 158636911
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-(2-aminopyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-[2-(hydroxymethyl)pyrimidin-5-yl]-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-(2-methoxypyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(2-methylpyrimidin-5-yl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(6-morpholin-4-yl-3-pyridinyl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-1-piperidin-4-yl-9-(6-pyrazol-1-yl-3-pyridinyl)-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one
9-(2-aminopyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-[2-(hydroxymethyl)pyrimidin-5-yl]-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-(2-methoxypyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(2-methylpyrimidin-5-yl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(6-morpholin-4-yl-3-pyridinyl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-1-piperidin-4-yl-9-(6-pyrazol-1-yl-3-pyridinyl)-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one (PubChem CID 158636911) has the molecular formula C158H176N52O10 and a molecular weight of 2963.50 g/mol. Its IUPAC name is 9-(2-aminopyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-[2-(hydroxymethyl)pyrimidin-5-yl]-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-(2-methoxypyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(2-methylpyrimidin-5-yl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(6-morpholin-4-yl-3-pyridinyl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-1-piperidin-4-yl-9-(6-pyrazol-1-yl-3-pyridinyl)-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one.
Molecular Properties
| Compound Name | 9-(2-aminopyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-[2-(hydroxymethyl)pyrimidin-5-yl]-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-(2-methoxypyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(2-methylpyrimidin-5-yl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(6-morpholin-4-yl-3-pyridinyl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-1-piperidin-4-yl-9-(6-pyrazol-1-yl-3-pyridinyl)-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one |
|---|---|
| PubChem CID | 158636911 |
| Molecular Formula | C158H176N52O10 |
| Molecular Weight | 2963.50 g/mol |
| Exact Mass | 2961.49 |
| IUPAC Name | 9-(2-aminopyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-[2-(hydroxymethyl)pyrimidin-5-yl]-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-(2-methoxypyrimidin-5-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(2-methylpyrimidin-5-yl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-9-(6-morpholin-4-yl-3-pyridinyl)-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;3-methyl-1-piperidin-4-yl-9-(6-pyrazol-1-yl-3-pyridinyl)-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one |
| SMILES | CN1CCN(c2ccc(-c3ccc4ncc5c(c4n3)N(C3CCNCC3)C(=O)N(C)C5)cn2)CC1.CN1Cc2cnc3ccc(-c4ccc(-n5cccn5)nc4)nc3c2N(C2CCNCC2)C1=O.CN1Cc2cnc3ccc(-c4ccc(N5CCOCC5)nc4)nc3c2N(C2CCNCC2)C1=O.CN1Cc2cnc3ccc(-c4cnc(CO)nc4)nc3c2N(C2CCNCC2)C1=O.CN1Cc2cnc3ccc(-c4cnc(N)nc4)nc3c2N(C2CCNCC2)C1=O.COc1ncc(-c2ccc3ncc4c(c3n2)N(C2CCNCC2)C(=O)N(C)C4)cn1.Cc1ncc(-c2ccc3ncc4c(c3n2)N(C2CCNCC2)C(=O)N(C)C4)cn1 |
| InChI | InChI=1S/C26H32N8O.C25H29N7O2.C24H24N8O.2C21H23N7O2.C21H23N7O.C20H22N8O/c1-31-11-13-33(14-12-31)23-6-3-18(15-29-23)21-4-5-22-24(30-21)25-19(16-28-22)17-32(2)26(35)34(25)20-7-9-27-10-8-20;1-30-16-18-15-27-21-4-3-20(17-2-5-22(28-14-17)31-10-12-34-13-11-31)29-23(21)24(18)32(25(30)33)19-6-8-26-9-7-19;1-30-15-17-14-26-20-5-4-19(16-3-6-21(27-13-16)31-12-2-9-28-31)29-22(20)23(17)32(24(30)33)18-7-10-25-11-8-18;1-27-12-14-11-23-17-4-3-16(13-9-24-20(30-2)25-10-13)26-18(17)19(14)28(21(27)29)15-5-7-22-8-6-15;1-27-11-14-10-23-17-3-2-16(13-8-24-18(12-29)25-9-13)26-19(17)20(14)28(21(27)30)15-4-6-22-7-5-15;1-13-23-9-14(10-24-13)17-3-4-18-19(26-17)20-15(11-25-18)12-27(2)21(29)28(20)16-5-7-22-8-6-16;1-27-11-13-10-23-16-3-2-15(12-8-24-19(21)25-9-12)26-17(16)18(13)28(20(27)29)14-4-6-22-7-5-14/h3-6,15-16,20,27H,7-14,17H2,1-2H3;2-5,14-15,19,26H,6-13,16H2,1H3;2-6,9,12-14,18,25H,7-8,10-11,15H2,1H3;3-4,9-11,15,22H,5-8,12H2,1-2H3;2-3,8-10,15,22,29H,4-7,11-12H2,1H3;3-4,9-11,16,22H,5-8,12H2,1-2H3;2-3,8-10,14,22H,4-7,11H2,1H3,(H2,21,24,25) |
| InChIKey | HZWOGNMNYJPACX-UHFFFAOYSA-N |
| XLogP | 16.45 |
| TPSA | 663.56 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 48 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 220 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2963.50 |
| LogP ≤ 5 | 16.45 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 48 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158636911 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.